Stay updated on Pembrolizumab+Cisplatin+IMRT in Head & Neck Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab+Cisplatin+IMRT in Head & Neck Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab+Cisplatin+IMRT in Head & Neck Cancer Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    Page updated from v3.0.1 to v3.0.2, and the 'Back to Top' element was removed.
    Difference
    0.7%
    Check dated 2025-09-14T19:55:54.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.
    Difference
    0.7%
    Check dated 2025-09-07T16:58:39.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a facility name and location details, while removing specific state, country, and city information.
    Difference
    19%
    Check dated 2025-08-31T12:11:47.000Z thumbnail image
  4. Check
    22 days ago
    No Change Detected
  5. Check
    30 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.11 to version 2.16.12.
    Difference
    0.3%
    Check dated 2025-08-17T04:39:55.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.10 to version 2.16.11.
    Difference
    0.3%
    Check dated 2025-08-10T00:32:32.000Z thumbnail image
  7. Check
    45 days ago
    Change Detected
    Summary
    The web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.
    Difference
    4%
    Check dated 2025-08-01T18:55:41.000Z thumbnail image

Stay in the know with updates to Pembrolizumab+Cisplatin+IMRT in Head & Neck Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab+Cisplatin+IMRT in Head & Neck Cancer Clinical Trial page.